The potential of induced pluripotent stem cell derived hepatocytes

Journal of Hepatology

Volumn 65, Issue 1, 2016, Pages 182-199

  Hannoun, Zara ^b   Steichen, Clara ^b   Dianat, Noushin ^b   Weber, Anne ^b   Dubart Kupperschmitt, Anne ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b Universite Paris Sud   (France)

Author keywords

Directed differentiation; Disease modelling; Drug screening; Genomic integrity; Human induced pluripotent stem cells (hiPSCs); Regenerative medicine; Toxicology studies

Indexed keywords

ACYLTRANSFERASE; CYTOCHROME P450; DEXAMETHASONE; GLUTATHIONE TRANSFERASE; HYDROCORTISONE;

BIOENGINEERING; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL ISOLATION; CELL THERAPY; COCULTURE; CYTOMETRY; DISEASE MODEL; DRUG DEVELOPMENT; DRUG SCREENING; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; GENOME; HUMAN; IMMUNOCYTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELL; LIVER CELL; LIVER REGENERATION; LIVER TRANSPLANTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANIMAL; ARTIFICIAL LIVER; REGENERATIVE MEDICINE;

ANIMALS; CELL DIFFERENTIATION; HEPATOCYTES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LIVER, ARTIFICIAL; REGENERATIVE MEDICINE;

EID: 84965067415     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.02.025     Document Type: Review

References (191)

1. A. Dhawan Clinical human hepatocyte transplantation- current status and challenges Liver Transpl 21 Suppl 1 2015 S39 S44
2. R. Hegarty, N. Hadzic, P. Gissen, and A. Dhawan Inherited metabolic disorders presenting as acute liver failure in newborns and young children: King's College Hospital experience Eur J Pediatr 174 2015 1387 1392
3. S.J. Forbes, S. Gupta, and A. Dhawan Cell therapy for liver disease: from liver transplantation to cell factory J Hepatol 62 2015 S157 S169
4. S.N. Bhatia, G.H. Underhill, K.S. Zaret, and I.J. Fox Cell and tissue engineering for liver disease Sci Transl Med 6 2014 245sr242
5. M.J. Gomez-Lechon, M.T. Donato, J.V. Castell, and R. Jover Human hepatocytes in primary culture: the choice to investigate drug metabolism in man Curr Drug Metab 5 2004 443 462
6. N.J. Hewitt, M.J. Lechon, J.B. Houston, D. Hallifax, H.S. Brown, P. Maurel, and et al. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies Drug Metab Rev 39 2007 159 234
7. A.A. Palakkan, D.C. Hay, P.R. Anil Kumar, T.V. Kumary, and J.A. Ross Liver tissue engineering and cell sources: issues and challenges Liver Int 33 2013 666 676
8. M.T. Donato, A. Lahoz, J.V. Castell, and M.J. Gomez-Lechon Cell lines: a tool for in vitro drug metabolism studies Curr Drug Metab 9 2008 1 11
9. C. Aninat, A. Piton, D. Glaise, T. Le Charpentier, S. Langouet, F. Morel, and et al. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells Drug Metab Dispos 34 2006 75 83
10. Y. Takeuchi, and R.A. Weiss Xenotransplantation: reappraising the risk of retroviral zoonosis Curr Opin Immunol 12 2000 504 507
11. S. Raab, M. Klingenstein, S. Liebau, and L. Linta A comparative view on human somatic cell sources for iPSC generation Stem Cells Int 2014 2014 768391
12. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
13. F. Soldner, D. Hockemeyer, C. Beard, Q. Gao, G.W. Bell, E.G. Cook, and et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors Cell 136 2009 964 977
14. N. Fusaki, H. Ban, A. Nishiyama, K. Saeki, and M. Hasegawa Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome Proc Jpn Acad Ser B Phys Biol Sci 85 2009 348 362
15. J. Yu, K. Hu, K. Smuga-Otto, S. Tian, R. Stewart, I.I. Slukvin, and et al. Human induced pluripotent stem cells free of vector and transgene sequences Science 324 2009 797 801
16. N. Miyoshi, H. Ishii, H. Nagano, N. Haraguchi, D.L. Dewi, Y. Kano, and et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs Cell Stem Cell 8 2011 633 638
17. L. Warren, P.D. Manos, T. Ahfeldt, Y.H. Loh, H. Li, F. Lau, and et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA Cell Stem Cell 7 2010 618 630
18. P. Hou, Y. Li, X. Zhang, C. Liu, J. Guan, H. Li, and et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds Science 341 2013 651 654
19. T. Aasen, A. Raya, M.J. Barrero, E. Garreta, A. Consiglio, F. Gonzalez, and et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes Nat Biotechnol 26 2008 1276 1284
20. T. Seki, S. Yuasa, and K. Fukuda Derivation of induced pluripotent stem cells from human peripheral circulating T cells Current protocols in stem cell biology Chapter 4 2011 Unit4A 3
21. I. Geti, M.L. Ormiston, F. Rouhani, M. Toshner, M. Movassagh, J. Nichols, and et al. A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells Stem Cells Transl Med 1 2012 855 865
22. X. Yan, H. Qin, C. Qu, R.S. Tuan, S. Shi, and G.T. Huang IPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin Stem Cells Dev 19 2010 469 480
23. T. Zhou, C. Benda, S. Dunzinger, Y. Huang, J.C. Ho, J. Yang, and et al. Generation of human induced pluripotent stem cells from urine samples Nat Protoc 7 2012 2080 2089
24. Y. Xue, X. Cai, L. Wang, B. Liao, H. Zhang, Y. Shan, and et al. Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells PLoS One 8 2013 e70573
25. M. Shafa, B. Day, A. Yamashita, G. Meng, S. Liu, R. Krawetz, and et al. Derivation of iPSCs in stirred suspension bioreactors Nat Methods 9 2012 465 466
26. M. Shafa, K. Sjonnesen, A. Yamashita, S. Liu, M. Michalak, M.S. Kallos, and et al. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors J Tissue Eng Regen Med 6 2012 462 472
27. G.J. Sullivan, D.C. Hay, I.H. Park, J. Fletcher, Z. Hannoun, C.M. Payne, and et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells Hepatology 51 2010 329 335
28. T. Takebe, K. Sekine, M. Enomura, H. Koike, M. Kimura, T. Ogaeri, and et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant Nature 499 2013 481 484
29. Y. Nagamoto, K. Tashiro, K. Takayama, K. Ohashi, K. Kawabata, F. Sakurai, and et al. The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets Biomaterials 33 2012 4526 4534
30. K. Takayama, K. Kawabata, Y. Nagamoto, K. Kishimoto, K. Tashiro, F. Sakurai, and et al. 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing Biomaterials 34 2013 1781 1789
31. S. Asgari, B. Pournasr, G.H. Salekdeh, A. Ghodsizadeh, M. Ott, and H. Baharvand Induced pluripotent stem cells: a new era for hepatology J Hepatol 53 2010 738 751
32. T.J. Rowland, L.M. Miller, A.J. Blaschke, E.L. Doss, A.J. Bonham, S.T. Hikita, and et al. Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin Stem Cells Dev 19 2010 1231 1240
33. R.E. Schwartz, H.E. Fleming, S.R. Khetani, and S.N. Bhatia Pluripotent stem cell-derived hepatocyte-like cells Biotechnol Adv 32 2014 504 513
34. M. Tada, and J.C. Smith Xwnt11 is a target of Xenopus Brachyury: regulation of gastrulation movements via Dishevelled, but not through the canonical Wnt pathway Development 127 2000 2227 2238
35. K.A. D'Amour, A.D. Agulnick, S. Eliazer, O.G. Kelly, E. Kroon, and E.E. Baetge Efficient differentiation of human embryonic stem cells to definitive endoderm Nat Biotechnol 23 2005 1534 1541
36. D.C. Hay, J. Fletcher, C. Payne, J.D. Terrace, R.C. Gallagher, J. Snoeys, and et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling Proc Natl Acad Sci U S A 105 2008 12301 12306
37. J.Y. Tan, G. Sriram, A.J. Rufaihah, K.G. Neoh, and T. Cao Efficient derivation of lateral plate and paraxial mesoderm subtypes from human embryonic stem cells through GSKi-mediated differentiation Stem Cells Dev 22 2013 1893 1906
38. D. Sinner, S. Rankin, M. Lee, and A.M. Zorn Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes Development 131 2004 3069 3080
39. A.M. Singh, D. Reynolds, T. Cliff, S. Ohtsuka, A.L. Mattheyses, Y. Sun, and et al. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation Cell Stem Cell 10 2012 312 326
40. A.K. Teo, I.A. Valdez, E. Dirice, and R.N. Kulkarni Comparable generation of activin-induced definitive endoderm via additive Wnt or BMP signaling in absence of serum Stem Cell Rep 3 2014 5 14
41. S.D. Vincent, N.R. Dunn, S. Hayashi, D.P. Norris, and E.J. Robertson Cell fate decisions within the mouse organizer are governed by graded Nodal signals Genes Dev 17 2003 1646 1662
42. A.B. McLean, K.A. D'Amour, K.L. Jones, M. Krishnamoorthy, M.J. Kulik, D.M. Reynolds, and et al. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed Stem Cells 25 2007 29 38
43. N.R. Hannan, C.P. Segeritz, T. Touboul, and L. Vallier Production of hepatocyte-like cells from human pluripotent stem cells Nat Protoc 8 2013 430 437
44. E.N. Tafaleng, S. Chakraborty, B. Han, P. Hale, W. Wu, A. Soto-Gutierrez, and et al. Induced pluripotent stem cells model personalized variations in liver disease resulting from alpha1-antitrypsin deficiency Hepatology 62 2015 147 157
45. L. Tolosa, J. Caron, Z. Hannoun, M. Antoni, S. Lopez, D. Burks, and et al. Transplantation of hESC-derived hepatocytes protects mice from liver injury Stem Cell Res Ther 6 2015 246
46. A.E. Serls, S. Doherty, P. Parvatiyar, J.M. Wells, and G.H. Deutsch Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung Development 132 2005 35 47
47. B.R. Degeorge Jr., M. Rosenberg, V. Eckstein, E. Gao, N. Herzog, H.A. Katus, and et al. BMP-2 and FGF-2 synergistically facilitate adoption of a cardiac phenotype in somatic bone marrow c-kit+/Sca-1+ stem cells Clin Transl Sci 1 2008 116 125
48. Y. Huang, C.D. Wright, S. Kobayashi, C.L. Healy, M. Elgethun, A. Cypher, and et al. GATA4 is a survival factor in adult cardiac myocytes but is not required for alpha1A-adrenergic receptor survival signaling Am J Physiol Heart Circ Physiol 295 2008 H699 H707
49. K.S. Zaret, J. Watts, J. Xu, E. Wandzioch, S.T. Smale, and T. Sekiya Pioneer factors, genetic competence, and inductive signaling: programming liver and pancreas progenitors from the endoderm Cold Spring Harb Symp Quant Biol 73 2008 119 126
50. K.M. Loh, L.T. Ang, J. Zhang, V. Kumar, J. Ang, J.Q. Auyeong, and et al. Efficient endoderm induction from human pluripotent stem cells by logically directing signals controlling lineage bifurcations Cell Stem Cell 14 2014 237 252
51. M. Sakaki-Yumoto, J. Liu, M. Ramalho-Santos, N. Yoshida, and R. Derynck Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state J Biol Chem 288 2013 18546 18560
52. H. Baharvand, S.M. Hashemi, and M. Shahsavani Differentiation of human embryonic stem cells into functional hepatocyte-like cells in a serum-free adherent culture condition Differentiation 76 2008 465 477
53. H. Basma, A. Soto-Gutierrez, G.R. Yannam, L. Liu, R. Ito, T. Yamamoto, and et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes Gastroenterology 136 2009 990 999
54. M. Vosough, E. Omidinia, M. Kadivar, M.A. Shokrgozar, B. Pournasr, N. Aghdami, and et al. Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture Stem Cells Dev 22 2013 2693 2705
55. D.C. Hay, S. Pernagallo, J.J. Diaz-Mochon, C.N. Medine, S. Greenhough, Z. Hannoun, and et al. Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism Stem Cell Res 6 2011 92 102
56. T. Touboul, N.R. Hannan, S. Corbineau, A. Martinez, C. Martinet, S. Branchereau, and et al. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development Hepatology 51 2010 1754 1765
57. J. Shan, R.E. Schwartz, N.T. Ross, D.J. Logan, D. Thomas, S.A. Duncan, and et al. Identification of small molecules for human hepatocyte expansion and iPS differentiation Nat Chem Biol 9 2013 514 520
58. R. Siller, S. Greenhough, E. Naumovska, and G.J. Sullivan Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells Stem Cell Rep 4 2015 939 952
59. Y. Kunisada, N. Tsubooka-Yamazoe, M. Shoji, and M. Hosoya Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells Stem Cell Res 8 2012 274 284
60. Y. Tahamtani, M. Azarnia, A. Farrokhi, A. Sharifi-Zarchi, N. Aghdami, and H. Baharvand Treatment of human embryonic stem cells with different combinations of priming and inducing factors toward definitive endoderm Stem Cells Dev 22 2013 1419 1432
61. M. van Wenum, R.A. Chamuleau, T.M. van Gulik, A. Siliakus, J. Seppen, and R. Hoekstra Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications Expert Opin Biol Ther 14 2014 1745 1760
62. M. Baxter, S. Withey, S. Harrison, C.P. Segeritz, F. Zhang, R. Atkinson-Dell, and et al. Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes J Hepatol 62 2015 581 589
63. M.T. Donato, A. Lahoz, S. Montero, A. Bonora, E. Pareja, J. Mir, and et al. Functional assessment of the quality of human hepatocyte preparations for cell transplantation Cell Transplant 17 2008 1211 1219
64. A. Bonora-Centelles, M.T. Donato, A. Lahoz, E. Pareja, J. Mir, J.V. Castell, and et al. Functional characterization of hepatocytes for cell transplantation: customized cell preparation for each receptor Cell Transplant 19 2010 21 28
65. L. Tolosa, S. Lopez, E. Pareja, M.T. Donato, A. Myara, T.H. Nguyen, and et al. Human neonatal hepatocyte transplantation induces long-term rescue of unconjugated hyperbilirubinemia in the Gunn rat Liver Transpl 21 2015 801 811
66. E. Schmelzer, L. Zhang, A. Bruce, E. Wauthier, J. Ludlow, H.L. Yao, and et al. Human hepatic stem cells from fetal and postnatal donors J Exp Med 204 2007 1973 1987
67. R.A. Turner, E. Wauthier, O. Lozoya, R. McClelland, J.E. Bowsher, C. Barbier, and et al. Successful transplantation of human hepatic stem cells with restricted localization to liver using hyaluronan grafts Hepatology 57 2013 775 784
68. A. Weber, J.P. Delgado, A. Parouchev, J. Branger, S. Mainot, A. Coulomb, and et al. Primate hepatic foetal progenitor cells and their therapeutic potential Pathol Biol (Paris) 54 2006 58 63
69. G. Carpino, V. Cardinale, R. Gentile, P. Onori, R. Semeraro, A. Franchitto, and et al. Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder J Hepatol 60 2014 1194 1202
70. V. Cardinale, G. Carpino, R. Gentile, C. Napoletano, H. Rahimi, A. Franchitto, and et al. Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis BMC Gastroenterol 14 2014 204
71. T. Cantz, A.D. Sharma, and M. Ott Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developments Stem Cells 33 2015 1055 1062
72. M. Kajiwara, T. Aoi, K. Okita, R. Takahashi, H. Inoue, N. Takayama, and et al. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells Proc Natl Acad Sci U S A 109 2012 12538 12543
73. I.H. Park, N. Arora, H. Huo, N. Maherali, T. Ahfeldt, A. Shimamura, and et al. Disease-specific induced pluripotent stem cells Cell 134 2008 877 886
74. N. Egawa, S. Kitaoka, K. Tsukita, M. Naitoh, K. Takahashi, T. Yamamoto, and et al. Drug screening for ALS using patient-specific induced pluripotent stem cells Sci Transl Med 4 2012 145ra104
75. N. Fujiwara, J. Shimizu, K. Takai, N. Arimitsu, Y. Ueda, S. Wakisaka, and et al. Cellular and molecular mechanisms of the restoration of human APP transgenic mouse cognitive dysfunction after transplant of human iPS cell-derived neural cells Exp Neurol 271 2015 423 431
76. A.M. Hossini, M. Megges, A. Prigione, B. Lichtner, M.R. Toliat, W. Wruck, and et al. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks BMC Genomics 16 2015 84
77. T. Kondo, M. Funayama, K. Tsukita, A. Hotta, A. Yasuda, S. Nori, and et al. Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice Stem Cell Rep 3 2014 242 249
78. K. Nieweg, A. Andreyeva, B. van Stegen, G. Tanriover, and K. Gottmann Alzheimer's disease-related amyloid-beta induces synaptotoxicity in human iPS cell-derived neurons Cell Death Dis 6 2015 e1709
79. F. Sampaziotis, C.P. Segeritz, and L. Vallier Potential of human induced pluripotent stem cells in studies of liver disease Hepatology 62 2015 303 311
80. K.D. Fairbanks, and A.S. Tavill Liver disease in alpha 1-antitrypsin deficiency: a review Am J Gastroenterol 103 2008 2136 2141 [quiz 2142]
81. S.T. Rashid, S. Corbineau, N. Hannan, S.J. Marciniak, E. Miranda, G. Alexander, and et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells J Clin Invest 120 2010 3127 3136
82. S. Zhang, S. Chen, W. Li, X. Guo, P. Zhao, J. Xu, and et al. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin Hum Mol Genet 20 2011 3176 3187
83. F. Yi, J. Qu, M. Li, K. Suzuki, N.Y. Kim, G.H. Liu, and et al. Establishment of hepatic and neural differentiation platforms of Wilson's disease specific induced pluripotent stem cells Protein Cell 3 2012 855 863
84. M.S. Brown, and J.L. Goldstein Biomedicine. Lowering LDL-not only how low, but how long? Science 311 2006 1721 1723
85. M.A. Cayo, J. Cai, A. DeLaForest, F.K. Noto, M. Nagaoka, B.S. Clark, and et al. JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia Hepatology 56 2012 2163 2171
86. T.L. Innerarity, K.H. Weisgraber, K.S. Arnold, R.W. Mahley, R.M. Krauss, G.L. Vega, and et al. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding Proc Natl Acad Sci U S A 84 1987 6919 6923
87. M. Abifadel, M. Varret, J.P. Rabes, D. Allard, K. Ouguerram, M. Devillers, and et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Nat Genet 34 2003 154 156
88. K. Si-Tayeb, S. Idriss, B. Champon, A. Caillaud, M. Pichelin, L. Arnaud, and et al. Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia Dis Model Mech 9 2015 81 90
89. A. Leung, S.K. Nah, W. Reid, A. Ebata, C.M. Koch, S. Monti, and et al. Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis Stem Cell Rep 1 2013 451 463
90. K. Isono, H. Jono, Y. Ohya, N. Shiraki, T. Yamazoe, A. Sugasaki, and et al. Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells Stem Cell Res 12 2014 574 583
91. D. Maetzel, S. Sarkar, H. Wang, L. Abi-Mosleh, P. Xu, A.W. Cheng, and et al. Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells Stem Cell Rep 2 2014 866 880
92. A.A. Wilson, L. Ying, M. Liesa, C.P. Segeritz, J.A. Mills, S.S. Shen, and et al. Emergence of a stage-dependent human liver disease signature with directed differentiation of alpha-1 antitrypsin-deficient iPS cells Stem Cell Rep 4 2015 873 885
93. K. Si-Tayeb, J.C. Duclos-Vallee, and M.A. Petit Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study gets personal J Hepatol 57 2012 689 691
94. M. Trevisan, A. Sinigaglia, G. Desole, A. Berto, M. Pacenti, G. Palu, and et al. Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems Viruses 7 2015 3835 3856
95. X. Wu, J.M. Robotham, E. Lee, S. Dalton, N.M. Kneteman, D.M. Gilbert, and et al. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation PLoS Pathog 8 2012 e1002617
96. T. Yoshida, K. Takayama, M. Kondoh, F. Sakurai, H. Tani, N. Sakamoto, and et al. Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection Biochem Biophys Res Commun 416 2011 119 124
97. A. Carpentier Jake Liang T Transplantation of iPS-derived hepatocytes into a mouse liver: a new murine model of hepatitis C virus infection Med Sci (Paris) 31 2015 256 259
98. A. Carpentier, A. Tesfaye, V. Chu, I. Nimgaonkar, F. Zhang, S.B. Lee, and et al. Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model J Clin Invest 124 2014 4953 4964
99. S. Ng, R.E. Schwartz, S. March, A. Galstian, N. Gural, J. Shan, and et al. Human iPSC-derived hepatocyte-like cells support Plasmodium liver-stage infection in vitro Stem Cell Rep 4 2015 348 359
100. K.I. Kaitin Deconstructing the drug development process: the new face of innovation Clin Pharmacol Ther 87 2010 356 361
101. I. Kola, and J. Landis Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3 2004 711 715
102. H. Pearson When good cholesterol turns bad Nature 444 2006 794 795
103. S. Wilkening, F. Stahl, and A. Bader Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties Drug Metab Dispos 31 2003 1035 1042
104. D.A. Mann Human induced pluripotent stem cell-derived hepatocytes for toxicology testing Expert Opin Drug Metab Toxicol 11 2015 1 5
105. O. Sirenko, J. Hesley, I. Rusyn, and E.F. Cromwell High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells Assay Drug Dev Technol 12 2014 43 54
106. D. Szkolnicka, S.L. Farnworth, B. Lucendo-Villarin, C. Storck, W. Zhou, J.P. Iredale, and et al. Accurate prediction of drug-induced liver injury using stem cell-derived populations Stem Cells Transl Med 3 2014 141 148
107. G. Holmgren, A.K. Sjogren, I. Barragan, A. Sabirsh, P. Sartipy, J. Synnergren, and et al. Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes Drug Metab Dispos 42 2014 1401 1406
108. B.R. Ware, D.R. Berger, and S.R. Khetani Prediction of drug-induced liver injury in micropatterned co-cultures containing iPSC-derived human hepatocytes Toxicol Sci 145 2015 252 262
109. S.S. Bale, L. Vernetti, N. Senutovitch, R. Jindal, M. Hegde, A. Gough, and et al. In vitro platforms for evaluating liver toxicity Exp Biol Med 239 2014 1180 1191
110. T. Bricks, P. Paullier, A. Legendre, M.J. Fleury, P. Zeller, F. Merlier, and et al. Development of a new microfluidic platform integrating co-cultures of intestinal and liver cell lines Toxicol In Vitro 28 2014 885 895
111. J.H. Sung, and M.L. Shuler A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs Lab Chip 9 2009 1385 1394
112. S.M. Choi, Y. Kim, J.S. Shim, J.T. Park, R.H. Wang, S.D. Leach, and et al. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells Hepatology 57 2013 2458 2468
113. A. Dhawan, S.C. Strom, E. Sokal, and I.J. Fox Human hepatocyte transplantation Methods Mol Biol 640 2010 525 534
114. G. Mazariegos, B. Shneider, B. Burton, I.J. Fox, N. Hadzic, P. Kishnani, and et al. Liver transplantation for pediatric metabolic disease Mol Genet Metab 111 2014 418 427
115. K.R. Vogel, A.A. Kennedy, L.A. Whitehouse, and K.M. Gibson Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects J Inherit Metab Dis 37 2014 165 176
116. K. Yamanouchi, H. Zhou, N. Roy-Chowdhury, F. Macaluso, L. Liu, T. Yamamoto, and et al. Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation Hepatology 49 2009 258 267
117. I.J. Fox, J.R. Chowdhury, S.S. Kaufman, T.C. Goertzen, N.R. Chowdhury, P.I. Warkentin, and et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation New Engl J Med 338 1998 1422 1426
118. J. Puppi, S.C. Strom, R.D. Hughes, S. Bansal, J.V. Castell, I. Dagher, and et al. Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London Cell Transplant 21 2012 1 10
119. H. Azuma, N. Paulk, A. Ranade, C. Dorrell, M. Al-Dhalimy, E. Ellis, and et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice Nat Biotechnol 25 2007 903 910
120. H. Strick-Marchand, M. Dusseaux, S. Darche, N.D. Huntington, N. Legrand, G. Masse-Ranson, and et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes PLoS One 10 2015 e0119820
121. I. Dagher, T.H. Nguyen, M.T. Groyer-Picard, P. Lainas, S. Mainot, C. Guettier, and et al. Efficient hepatocyte engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates Hepatology 49 2009 950 959
122. S. Asgari, M. Moslem, K. Bagheri-Lankarani, B. Pournasr, M. Miryounesi, and H. Baharvand Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells Stem Cell Rev 9 2013 493 504
123. Y. Chen, Y. Li, X. Wang, W. Zhang, V. Sauer, C.J. Chang, and et al. Amelioration of hyperbilirubinemia in Gunn rats after transplantation of human induced pluripotent stem cell-derived hepatocytes Stem Cell Rep 5 2015 22 30
124. J. Ding, G.R. Yannam, N. Roy-Chowdhury, T. Hidvegi, H. Basma, S.I. Rennard, and et al. Spontaneous hepatic repopulation in transgenic mice expressing mutant human alpha1-antitrypsin by wild-type donor hepatocytes J Clin Invest 121 2011 1930 1934
125. J.M. De Vree, R. Ottenhoff, P.J. Bosma, A.J. Smith, J. Aten, and R.P. Oude Elferink Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis Gastroenterology 119 2000 1720 1730
126. C.J. Taylor, S. Peacock, A.N. Chaudhry, J.A. Bradley, and E.M. Bolton Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types Cell Stem Cell 11 2012 147 152
127. J. Barry, J. Hyllner, G. Stacey, C.J. Taylor, and M. Turner Setting up a haplobank: issues and solutions Curr Stem Cell Rep 1 2015 110 117
128. K.N. Yarygin, A.Y. Lupatov, and I.V. Kholodenko Cell-based therapies of liver diseases: age-related challenges Clin Interv Aging 10 2015 1909 1924
129. K. Yusa, S.T. Rashid, H. Strick-Marchand, I. Varela, P.Q. Liu, D.E. Paschon, and et al. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells Nature 478 2011 391 394
130. M. Jinek, K. Chylinski, I. Fonfara, M. Hauer, J.A. Doudna, and E. Charpentier A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity Science 337 2012 816 821
131. C. Guguen-Guillouzo, and A. Guillouzo General review on in vitro hepatocyte models and their applications Methods Mol Biol 640 2010 1 40
132. S.N. Bhatia, M.L. Yarmush, and M. Toner Controlling cell interactions by micropatterning in co-cultures: hepatocytes and 3T3 fibroblasts J Biomed Mater Res 34 1997 189 199
133. S.R. Khetani, and S.N. Bhatia Microscale culture of human liver cells for drug development Nat Biotechnol 26 2008 120 126
134. Y.B. Kang, S. Rawat, J. Cirillo, M. Bouchard, and H.M. Noh Layered long-term co-culture of hepatocytes and endothelial cells on a transwell membrane: toward engineering the liver sinusoid Biofabrication 5 2013 045008
135. P. Krause, F. Saghatolislam, S. Koenig, K. Unthan-Fechner, and I. Probst Maintaining hepatocyte differentiation in vitro through co-culture with hepatic stellate cells In Vitro Cell Dev Biol Anim 45 2009 205 212
136. J.A. Sunman, R.L. Hawke, E.L. LeCluyse, and A.D. Kashuba Kupffer cell-mediated IL-2 suppression of CYP3A activity in human hepatocytes Drug Metab Dispos 32 2004 359 363
137. E. Fitzpatrick, Y. Wu, P. Dhadda, R.D. Hughes, R.R. Mitry, H. Qin, and et al. Coculture with mesenchymal stem cells results in improved viability and function of human hepatocytes Cell Transplant 24 2015 73 83
138. D. Marekova, P. Lesny, P. Jendelova, J. Michalek, P. Kostecka, M. Pradny, and et al. Hepatocyte growth on polycapronolactone and 2-hydroxyethylmethacrylate nanofiber sheets enhanced by bone marrow-derived mesenchymal stromal cells Hepatogastroenterology 60 2013 1156 1163
139. C. Du, K. Narayanan, M.F. Leong, and A.C. Wan Induced pluripotent stem cell-derived hepatocytes and endothelial cells in multi-component hydrogel fibers for liver tissue engineering Biomaterials 35 2014 6006 6014
140. S. Ogawa, J. Surapisitchat, C. Virtanen, M. Ogawa, M. Niapour, K.S. Sugamori, and et al. Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes Development 140 2013 3285 3296
141. K. Subramanian, D.J. Owens, R. Raju, M. Firpo, T.D. O'Brien, C.M. Verfaillie, and et al. Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cells Stem Cells Dev 23 2014 124 131
142. R.R. Zhang, T. Takebe, L. Miyazaki, M. Takayama, H. Koike, M. Kimura, and et al. Efficient hepatic differentiation of human induced pluripotent stem cells in a three-dimensional microscale culture Methods Mol Biol 1210 2014 131 141
143. M.J. Gomez-Lechon, L. Tolosa, I. Conde, and M.T. Donato Competency of different cell models to predict human hepatotoxic drugs Expert Opin Drug Metab Toxicol 10 2014 1553 1568
144. C. Lin, K.R. Ballinger, and S.R. Khetani The application of engineered liver tissues for novel drug discovery Expert Opin Drug Discov 10 2015 519 540
145. J. Fukuda, and K. Nakazawa Hepatocyte spheroid arrays inside microwells connected with microchannels Biomicrofluidics 5 2011 22205
146. A. Kobayashi, K. Yamakoshi, Y. Yajima, R. Utoh, M. Yamada, and M. Seki Preparation of stripe-patterned heterogeneous hydrogel sheets using microfluidic devices for high-density coculture of hepatocytes and fibroblasts J Biosci Bioeng 116 2013 761 767
147. J.M. Prot, O. Videau, C. Brochot, C. Legallais, H. Benech, and E. Leclerc A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening Int J Pharm 408 2011 67 75
148. E.M. Materne, A.P. Ramme, A.P. Terrasso, M. Serra, P.M. Alves, C. Brito, and et al. A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing J Biotechnol 205 2015 36 46
149. K. Rennert, S. Steinborn, M. Groger, B. Ungerbock, A.M. Jank, J. Ehgartner, and et al. A microfluidically perfused three dimensional human liver model Biomaterials 71 2015 119 131
150. G.G. Giobbe, F. Michielin, C. Luni, S. Giulitti, S. Martewicz, S. Dupont, and et al. Functional differentiation of human pluripotent stem cells on a chip Nat Methods 12 2015 637 640
151. B. Andria, A. Bracco, G. Cirino, and R.A.F.M. Chamuleau Liver cell culture devices Cell Med 1 2010 55 70
152. C. Selden, C.W. Spearman, D. Kahn, M. Miller, A. Figaji, E. Erro, and et al. Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational setting PLoS One 8 2013 e82312
153. G.A. Nibourg, R. Hoekstra, T.V. van der Hoeven, M.T. Ackermans, T.B. Hakvoort, T.M. van Gulik, and et al. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor Int J Biochem Cell Biol 45 2013 1860 1868
154. G.A. Nibourg, R.A. Chamuleau, T.M. van Gulik, and R. Hoekstra Proliferative human cell sources applied as biocomponent in bioartificial livers: a review Expert Opin Biol Ther 12 2012 905 921
155. C. Chan, F. Berthiaume, B.D. Nath, A.W. Tilles, M. Toner, and M.L. Yarmush Hepatic tissue engineering for adjunct and temporary liver support: critical technologies Liver Transpl 10 2004 1331 1342
156. R.C. Gessner, A.D. Hanson, S. Feingold, A.T. Cashion, A. Corcimaru, B.T. Wu, and et al. Functional ultrasound imaging for assessment of extracellular matrix scaffolds used for liver organoid formation Biomaterials 34 2013 9341 9351
157. B.E. Uygun, A. Soto-Gutierrez, H. Yagi, M.L. Izamis, M.A. Guzzardi, C. Shulman, and et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix Nat Med 16 2010 814 820
158. P.M. Baptista, M.M. Siddiqui, G. Lozier, S.R. Rodriguez, A. Atala, and S. Soker The use of whole organ decellularization for the generation of a vascularized liver organoid Hepatology 53 2011 604 617
159. H. Zhang, Y. Zhang, F. Ma, P. Bie, and L. Bai Orthotopic transplantation of decellularized liver scaffold in mice Int J Clin Exp Med 8 2015 598 606
160. I.K. Ko, L. Peng, A. Peloso, C.J. Smith, A. Dhal, D.B. Deegan, and et al. Bioengineered transplantable porcine livers with re-endothelialized vasculature Biomaterials 40 2015 72 79
161. K.H. Hussein, K.M. Park, H.M. Kim, P.K. Teotia, J.H. Ghim, and H.M. Woo Construction of a biocompatible decellularized porcine hepatic lobe for liver bioengineering Int J Artif Organs 38 2015 96 104
162. A. Peloso, A. Dhal, J.P. Zambon, P. Li, G. Orlando, A. Atala, and et al. Current achievements and future perspectives in whole-organ bioengineering Stem Cell Res Ther 6 2015 107
163. S.V. Murphy, and A. Atala 3D bioprinting of tissues and organs Nat Biotechnol 32 2014 773 785
164. J.B. Robbins, V. Gorgen, P. Min, B.R. Shepherd, and S.C. Presnell A novel in vitro three-dimensional bioprinted liver tissue FASEB J 27 2013 872.812
165. R. Chang, K. Emami, H. Wu, and W. Sun Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model Biofabrication 2 2010 045004
166. A. Skardal, M. Devarasetty, H.W. Kang, I. Mead, C. Bishop, T. Shupe, and et al. A hydrogel bioink toolkit for mimicking native tissue biochemical and mechanical properties in bioprinted tissue constructs Acta Biomater 25 2015 24 34
167. N. Dianat, H. Dubois-Pot-Schneider, C. Steichen, C. Desterke, P. Leclerc, A. Raveux, and et al. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells Hepatology 60 2014 700 714
168. M. Ogawa, S. Ogawa, C.E. Bear, S. Ahmadi, S. Chin, B. Li, and et al. Directed differentiation of cholangiocytes from human pluripotent stem cells Nat Biotechnol 33 2015 853 861
169. F. Sampaziotis, M. Cardoso de Brito, P. Madrigal, A. Bertero, K. Saeb-Parsy, F.A. Soares, and et al. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation Nat Biotechnol 33 2015 845 852
170. S. Benhamouche, T. Decaens, C. Godard, R. Chambrey, D.S. Rickman, C. Moinard, and et al. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver Dev Cell 10 2006 759 770
171. G. Gentric, and C. Desdouets Polyploidization in liver tissue Am J Pathol 184 2014 322 331
172. J.S. Draper, K. Smith, P. Gokhale, H.D. Moore, E. Maltby, J. Johnson, and et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells Nat Biotechnol 22 2004 53 54
173. C. Steichen, E. Luce, J. Maluenda, L. Tosca, I. Moreno-Gimeno, C. Desterke, and et al. Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity Stem Cells Transl Med 3 2014 686 691
174. A. Gore, Z. Li, H.L. Fung, J.E. Young, S. Agarwal, J. Antosiewicz-Bourget, and et al. Somatic coding mutations in human induced pluripotent stem cells Nature 471 2011 63 67
175. Y. Shen, Y. Matsuno, S.D. Fouse, N. Rao, S. Root, R. Xu, and et al. X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations Proc Natl Acad Sci U S A 105 2008 4709 4714
176. G. Liang, and Y. Zhang Genetic and epigenetic variations in iPSCs: potential causes and implications for application Cell Stem Cell 13 2013 149 159
177. B. Nashun, P.W. Hill, and P. Hajkova Reprogramming of cell fate: epigenetic memory and the erasure of memories past EMBO J 34 2015 1296 1308
178. Z. Zhang, and W.S. Wu Sodium butyrate promotes generation of human induced pluripotent stem cells through induction of the miR302/367 cluster Stem Cells Dev 22 2013 2268 2277
179. K. Kim, R. Zhao, A. Doi, K. Ng, J. Unternaehrer, P. Cahan, and et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells Nat Biotechnol 29 2011 1117 1119
180. A. Abyzov, J. Mariani, D. Palejev, Y. Zhang, M.S. Haney, L. Tomasini, and et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells Nature 492 2012 438 442
181. A. Piotrowski, C.E. Bruder, R. Andersson, T. Diaz de Stahl, U. Menzel, J. Sandgren, and et al. Somatic mosaicism for copy number variation in differentiated human tissues Hum Mutat 29 2008 1118 1124
182. S.M. Hussein, N.N. Batada, S. Vuoristo, R.W. Ching, R. Autio, E. Narva, and et al. Copy number variation and selection during reprogramming to pluripotency Nature 471 2011 58 62
183. T.M. Schlaeger, L. Daheron, T.R. Brickler, S. Entwisle, K. Chan, A. Cianci, and et al. A comparison of non-integrating reprogramming methods Nat Biotechnol 33 2015 58 63
184. J. Ji, V. Sharma, S. Qi, M.E. Guarch, P. Zhao, Z. Luo, and et al. Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells Stem Cell Rep 2 2014 44 51
185. L.C. Laurent, I. Ulitsky, I. Slavin, H. Tran, A. Schork, R. Morey, and et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture Cell Stem Cell 8 2011 106 118
186. I. Garitaonandia, H. Amir, F.S. Boscolo, G.K. Wambua, H.L. Schultheisz, K. Sabatini, and et al. Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions PLoS One 10 2015 e0118307
187. Q. Bai, J.M. Ramirez, F. Becker, V. Pantesco, T. Lavabre-Bertrand, O. Hovatta, and et al. Temporal analysis of genome alterations induced by single-cell passaging in human embryonic stem cells Stem Cells Dev 24 2015 653 662
188. N.L. Corrales, K. Mrasek, M. Voigt, T. Liehr, and N. Kosyakova Copy number variations (CNVs) in human pluripotent cell-derived neuroprogenitors Gene 506 2012 377 379
189. M. Perry, and R. Chalkley Histone acetylation increases the solubility of chromatin and occurs sequentially over most of the chromatin. A novel model for the biological role of histone acetylation J Biol Chem 257 1982 7336 7347
190. J.R. MacDonald, R. Ziman, R.K. Yuen, L. Feuk, and S.W. Scherer The Database of Genomic Variants: a curated collection of structural variation in the human genome Nucleic Acids Res 42 2014 D986 D992
191. J. Wang, G.S. Pang, S.S. Chong, and C.G. Lee SNP web resources and their potential applications in personalized medicine Curr Drug Metab 13 2012 978 990